Affinity Asset Advisors, LLC
- SEC CIK
- 0001773195
- Latest filing
- Aug 13, 2026
INZY holding history
Inozyme Pharma, Inc. in every 13F filed by Affinity Asset Advisors, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
INZY overviewAll 13F holders of INZYFull Q2 2026 holdings
- Shares (Q3 2025)
- 0
- Sold out in Q3 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 11
- Since Q4 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q3 2025 | 0 | $0 | 0.0% | −1,749,359−100.0% | Sold out | Holders |
| Q2 2025 | 1,749,359 | $7.00M | 1.0% | −2,118,351−54.8% | Reduced | Holders |
| Q1 2025 | 3,867,710 | $3.52M | 0.6% | −104,608−2.6% | Reduced | Holders |
| Q4 2024 | 3,972,318 | $11.0M | 1.7% | +1,150,000+40.7% | Added | Holders |
| Q3 2024 | 2,822,318 | $14.8M | 2.3% | −33,934−1.2% | Reduced | Holders |
| Q2 2024 | 2,856,252 | $12.7M | 2.0% | +213,733+8.1% | Added | Holders |
| Q1 2024 | 2,642,519 | $20.2M | 3.3% | +756,717+40.1% | Added | Holders |
| Q4 2023 | 1,885,802 | $8.03M | 1.6% | +505,950+36.7% | Added | Holders |
| Q3 2023 | 1,379,852 | $5.80M | 1.9% | +628,056+83.5% | Added | Holders |
| Q2 2023 | 751,796 | $4.19M | 1.6% | 00.0% | Unchanged | Holders |
| Q1 2023 | 751,796 | $4.31M | 1.7% | +251,796+50.4% | Added | Holders |
| Q4 2022 | 500,000 | $525.0K | 0.2% | +500,000 | New | Holders |